Surgical resection after chemotherapy for advanced cervical carcinoma;Place de la chirurgie après chimioradiothérapie des cancers du col localement évolués

Cancer/Radiotherapie

Volumn 10, Issue 6-7, 2006, Pages 471-476

  Houvenaeghel, G ^a   Buttarelli, M ^a   de Troyer, J ^a   Carcopino, X ^a   Lelievre L ^a   Tallet, A ^a   Goncalves, A ^a   Jacquemier, J ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Advanced uterine cervix carcinoma; Chemotherapy; Radiotherapy; Results and morbidity; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL;

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER SURGERY; CANCER SURVIVAL; CERVICAL GANGLION; DISEASE FREE SURVIVAL; HUMAN; MORBIDITY; OVERALL SURVIVAL; PELVIC DISEASE; PRIORITY JOURNAL; SHORT SURVEY; UTERINE CERVIX CARCINOMA; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UTERINE CERVIX TUMOR;

BRACHYTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 33750434822     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.07.002     Document Type: Short Survey

References (18)

1. Bernard A., Touboul E., Lefranc J.P., Deniaud-Alexandre E., Genestie C., Uzan S., et al. Epidermoid carcinoma of the uterine cervix at operable bulky stages IB and II treated with combined primary radiation therapy and surgery. Cancer Radiother. 6 (2002) 85-98
2. Bourguet P., Hitzel A., Houvenaeghel G., Vinatier D., Bosquet L., Bonichon F., et al., Standards Options et Recommandations, Institut national du cancer, Fédération nationale des centres de lutte contre le cancer, Ligue nationale contre le cancer, SFMN ; Fédération hospitalière de France, Fédération nationale de cancérologie des CHRU, Fédération française de cancérologie. Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus. Bull. Cancer 93 (2006) 385-390
3. Classe J.M., Rauch P., Rodier J.F., Morice P., Stoeckle E., Lasry S., et al. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des chirurgiens de centre de lutte contre le cancer). Gynecol. Oncol. (2006) (In Press)
4. Distefano M., Fagotti A., Ferrandina G., Fanfani F., Smaniotto D., and D'Agostino G. Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications. Gynecol. Oncol. 99 (2005) S166-S170
5. Green J.A., Kirwan J.M., Tierney J.F., Symonds P., Fresco L., Collingwood M., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
6. Houvenaeghel G., Lelievre L., Gonzague-Casabianca L., Buttarelli M., Moutardier V., Goncalves A., et al. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol. Oncol. 100 (2006) 338-343
7. Houvenaeghel G., Lelievre L., Rigouard A.L., Buttarelli M., Jacquemier J., Viens P., et al. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol. Oncol. 102 (2006) 74-79
8. Houvenaeghel G., Martino M., Resbeut M., Rosello R., Perez T., Delpero J.R., et al. Pelvic staging of advanced and recurrent gynecologic cancers: contribution of endosonography. Gynecol. Oncol. 55 (1994) 393-400
9. Jurado M., Martinez-Monge R., Garcia-Foncillas J., Azinovic I., Aristu J., Lopez-Garcia G., et al. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery ± intraoperative electron beam radiotherapy in locally advanced cervical cancer. Gynecol. Oncol. 74 (1999) 30-37
10. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with. Radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340 (1999) 1154-1161
11. Keys H.M., Bundy B.N., Stehman F.B., Okagaki T., Gallup D.G., Burnett A.F., et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol. Oncol. 89 (2003) 343-353
12. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340 (1999) 1137-1143
13. Paley P.J. The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma. Gynecol. Oncol. 76 (2000) 373-379
14. Peters W.A., Liu P.Y., Barret R.J., Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18 (2000) 1606-1613
15. Resbeut M., Cowen D., Viens P., Noirclerc M., Perez T., Gouvernet J., et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol. Oncol. 54 (1994) 68-75
16. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340 (1999) 1144-1153
17. Mauriac L. Fédération nationale des centres de lutte contre le cancer. Standard, options et recommandations 3. Cancer invasif du col utérin. Stade non métastatique (1996), Arnette Blackwell, Paris
18. Withney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes : a Gynecologic Oncology Group and Southwest Oncology Group study. J. Clin. Oncol. 17 (1999) 1339-1348